Ontology highlight
ABSTRACT:
SUBMITTER: Ruiz-Palacios GM
PROVIDER: S-EPMC5215410 | biostudies-literature | 2016 Dec
REPOSITORIES: biostudies-literature
Ruiz-Palacios Guillermo M GM Leroux-Roels Geert G Beran Jiri J Devaster Jeanne-Marie JM Esen Meral M Launay Odile O McElhaney Janet E JE van Essen Gerrit A GA Benoit Anne A Claeys Carine C Dewé Walthère W Durand Christelle C Duval Xavier X Falsey Ann R AR Feldman Gregory G Galtier Florence F Gervais Pierre P Hwang Shinn-Jang SJ McNeil Shelly S Richardus Jan Hendrik JH Trofa Andrew A Oostvogels Lidia L
Human vaccines & immunotherapeutics 20161201 12
In this study we describe the immunogenicity results from a subset of older people (N = 5187) who participated in a Phase 3 randomized, observer-blinded trial of AS03-TIV versus TIV (Fluarix™) (ClinicalTrials.gov, NCT00753272). Participants received one dose of AS03-TIV or TIV in each study year and antibody titers against the vaccine strains were assessed using hemagglutination-inhibition (HI) assay at 21 d and 180 d post-vaccination in each vaccine group in the 2008/09 (Year 1) and 2009/10 (Ye ...[more]